<!doctype html>

<!--[if lt IE 7]>

	<html lang="en-US" class="no-js lt-ie11 lt-ie10 lt-ie9 lt-ie8 lt-ie7">

<![endif]-->

<!--[if IE 7]>

	<html lang="en-US" class="no-js lt-ie11 lt-ie10 lt-ie9 lt-ie8 ie7">

<![endif]-->

<!--[if IE 8]>

	<html lang="en-US" class="no-js lt-ie11 lt-ie10 lt-ie9 ie8">

<![endif]-->

<!--[if IE 9]>

	<html lang="en-US" class="no-js lt-ie11 lt-ie10 ie9">

<![endif]-->

<!--[if IE 10]>

	<html lang="en-US" class="no-js lt-ie11 ie10">

<![endif]-->

<!--[if gt IE 10]><!-->

	<html lang="en-US" class="no-js">

<!--<![endif]-->

<head>

	<meta charset="utf-8" />

	<!--[if IE]>

		<meta http-equiv="X-UA-Compatible" content="IE=edge, chrome=1" />

	<![endif]-->

	<title>Boston Scientific | 2013 Online Annual Report</title>

	<meta name="description" content="" />

	<meta name="keywords" content="" />

	<meta name="author" content="" />

	<meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0" />

	<meta name="google-site-verification" content="" />

	<link rel="shortcut icon" href="a/img/favicon.png" />

	<link rel="apple-touch-icon" href="a/img/touch-icon.png" />

	<link type="text/css" href="a/css/screen.css" rel="stylesheet" media="screen, projection" />

	<link type="text/css" href="a/css/print.css" rel="stylesheet" media="print" />

	<link type="text/css" href="a/css/charts.css" rel="stylesheet" />

	<link type="text/css" href="a/css/fonts.css" rel="stylesheet" />

	<script src="a/js/modernizr.js"></script>

	<meta name="twitter:card" content="" />
	<meta name="twitter:site" content="" />
	<meta name="twitter:title" content="" />
	<meta name="twitter:description" content="" />
	<meta name="twitter:url" content="" />

	<meta property="og:title" content="" />
	<meta property="og:description" content="" />
	<meta property="og:url" content="" />
	<meta property="og:image" content="" />


                    <script>var w=window;if(w.performance||w.mozPerformance||w.msPerformance||w.webkitPerformance){var d=document,AKSB=AKSB||{};AKSB.q=[],AKSB.mark=function(e,_){AKSB.q.push(["mark",e,_||(new Date).getTime()])},AKSB.measure=function(e,_,t){AKSB.q.push(["measure",e,_,t||(new Date).getTime()])},AKSB.done=function(e){AKSB.q.push(["done",e])},AKSB.mark("firstbyte",(new Date).getTime()),AKSB.prof={custid:"286004",ustr:"",originlat:"0",clientrtt:"34",ghostip:"165.254.57.148",ipv6:false,pct:"10",clientip:"67.235.127.191",requestid:"b7c5a6",region:"20363",protocol:"",blver:12,akM:"a",akN:"ae",akTT:"O",akTX:"1",akTI:"b7c5a6",ai:"175156",ra:"false",pmgn:"",pmgi:"",pmp:"",qc:""},function(e){var _=d.createElement("script");_.async="async",_.src=e;var t=d.getElementsByTagName("script"),t=t[t.length-1];t.parentNode.insertBefore(_,t)}(("https:"===d.location.protocol?"https:":"http:")+"//ds-aksb-a.akamaihd.net/aksb.min.js")}</script>
                    </head>

<body id="corporate-information" class="full-width">

	<!--[if lt IE 8]>

		<div class="browse-happy">

			<p>You are using an <strong>outdated</strong> browser. Please <a href="http://browsehappy.com/">upgrade your browser</a> to improve your experience.</p>

		</div>

	<![endif]-->

	<header id="header" role="banner">

		<div class="wrap">

			<div id="logo">

				<a href="index.html">Boston Scientific <em>Advancing science for life&trade;</em></a>

			</div>

			<div class="annual-report">

				<b>2013</b> Online Annual Report

			</div>

			<nav id="nav" role="navigation">

				<div class="toggle">

					<span>Menu</span>

				</div>

				<ul>
				
				<li class="transforming-lives">

						<a href="transforming-lives.html">Transforming Lives</a>

					</li>


					<li class="financial-highlights">

						<a href="financial-highlights.html">Financial Highlights</a>

					</li>

					<li class="letter">

						<a href="letter.html">Letter</a>

					</li>

			
					<li class="our-mission">

						<a href="our-mission.html">Our Mission</a>

					</li>

					<li class="business-highlights">

						<a href="business-highlights.html">Business Overviews</a>

					</li>

					<li class="meaningful-innovation">

						<a href="meaningful-innovation.html">Meaningful Innovation</a>

					</li>

					<li class="corporate-information">

						<a href="corporate-information.html">Corporate Information</a>

					</li>

					<li class="form-10-k">

						<a href="pdf/form-10k.pdf" target="_blank">Form 10-K</a>


					</li>

				</ul>

			</nav>

		</div>

	</header>

	<div id="content">

		<div class="wrap">

			<div id="main" role="main">

				<h1>Corporate Information</h1>

				<section class="board-of-directors">

					<header>

						<h2 class="title">Board of Directors</h2>

					</header>

					<div class="content">

						<ul>

							<li>

								<b>Katharine T. Bartlett <sup>2,3</sup></b>

								Director; A. Kenneth Pye<br />Professor of Law,<br />Duke University School of Law

							</li>

							<li>

								<b>Bruce L. Byrnes <sup>1,3</sup></b>

								Director; Retired Vice Chairman of the Board,<br />The Procter and Gamble Company

							</li>

							<li>

								<b>Nelda J. Connors <sup>4,5</sup></b>

								Director; Founder, Chairwoman<br />and Chief Executive Officer,<br />Pine Grove Holdings, LLC

							</li>

							<li>

								<b>Kristina M. Johnson, Ph.D. <sup>2,4</sup></b>

								Director; Chief Executive Officer,<br />Enduring Hydro, LLC

							</li>

							<li>

								<b>Edward J. Ludwig</b>

								Director; Former Chief Executive Ofﬁcer,<br />President and Chairman,<br />Becton, Dickinson and Company

							</li>

							<li>

								<b>Michael F. Mahoney</b>

								Director; President and<br />Chief Executive Officer

							</li>

							<li>

								<b>Ernest Mario, Ph.D. <sup>1,2</sup></b>

								Director; Executive Chairman,<br />Capnia, Inc.

							</li>

							<li>

								<b>N.J. Nicholas, Jr. <sup>4</sup></b>

								Director; Private Investor

							</li>

							<li>

								<b>Pete M. Nicholas</b>

								Director; Chairman of the Board;<br />Co-Founder

							</li>

							<li>

								<b>Uwe E. Reinhardt, Ph.D. <sup>1,5</sup></b>

								Director; Professor of<br />Economics and Public Affairs,<br />Princeton University

							</li>

							<li>

								<b>David J. Roux</b>

								Director; Co-Founder and Senior Director,<br />Silver Lake

							</li>

							<li>

								<b>John E. Sununu <sup>3,5</sup></b>

								Director; Former U.S. Senator

							</li>

							<li>

								<b>Director Emeritus</b><br />
								<b>John E. Abele</b>

								Director Emeritus; Co-Founder

							</li>

							<li class="notes">

								<p>Information is accurate as of March 1, 2014.</p>

								<ol>

									<li>Member of the Audit Committee</li>
									<li>Member of the Executive Compensation and Human Resources Committee</li>
									<li>Member of the Nominating and Governance Committee</li>
									<li>Member of the Finance Committee</li>
									<li>Member of the Compliance and Quality Committee</li>

								</ol>

							</li>

							<li class="gap"></li>

						</ul>

					</div>

				</section>

				<section class="executive-officers">

					<header>

						<h2 class="title">Executive Officers</h2>

					</header>

					<div class="content">

						<ul>

							<li>

								<b>Kevin J. Ballinger</b>

								Senior Vice President and President,<br />Interventional Cardiology

							</li>

							<li>

								<b>Supratim Bose</b>

								Executive Vice President and President,<br />Asia-Pacific, Middle East and Africa (AMEA)

							</li>

							<li>

								<b>Daniel J. Brennan</b>

								Executive Vice President and<br />Chief Financial Officer

							</li>

							<li>

								<b>Wendy Carruthers</b>

								Senior Vice President,<br />Human Resources

							</li>

							<li>

								<b>Keith D. Dawkins, M.D.</b>

								Executive Vice President and<br />Global Chief Medical Officer

							</li>

							<li>

								<b>Joseph M. Fitzgerald</b>

								Executive Vice President and President,<br />Rhythm Management

							</li>

							<li>

								<b>Jean Fitterer Lance</b>

								Senior Vice President and<br />Chief Compliance Officer

							</li>

							<li>

								<b>Michael F. Mahoney</b>

								President and Chief Executive Officer

							</li>

							<li>

								<b>Jeffrey B. Mirviss</b>

								Senior Vice President and President,<br />Peripheral Interventions

							</li>

							<li>

								<b>Maulik Nanavaty</b>

								Senior Vice President and President,<br />Neuromodulation

							</li>

							<li>

								<b>J. Michael Onuscheck</b>

								Senior Vice President and President,<br />Europe

							</li>

							<li>

								<b>Michael P. Phalen</b>

								Executive Vice President and President,<br />MedSurg

							</li>

							<li>

								<b>David A. Pierce</b>

								Senior Vice President and President,<br />Endoscopy

							</li>

							<li>

								<b>Karen Prange</b>

								Senior Vice President and President,<br />Urology and Women’s Health

							</li>

							<li>

								<b>Timothy A. Pratt</b>

								Executive Vice President,<br />Chief Administrative Officer,<br />General Counsel and Secretary

							</li>

							<li>

								<b>Kenneth J. Pucel</b>

								Executive Vice President,<br />Global Operations,<br />Quality and Technology

							</li>

							<li class="gap"></li>

						</ul>

					</div>

				</section>

				<section class="stockholder-information">

					<header>

						<h2 class="title">Stockholder Information</h2>

					</header>

					<div class="content">

						<h3>Stock Listing</h3>

						<p>Boston Scientific Corporation common stock is traded on the NYSE under the symbol &ldquo;BSX.&rdquo;</p>

						<h3>Transfer Agent</h3>

						<p>Inquiries concerning the transfer or exchange of shares, lost stock certificates, duplicate mailings, or changes of address should be directed to the Company’s Transfer Agent at:</p>

						<div class="vcard">

							<div class="fn n org">Computershare Inc.</div>

							<div class="adr">

								<div class="street-address">P.O. Box 30170</div>

								<span class="locality">College Station</span>,

								<span class="region">TX</span>,

								<span class="postal-code">77842-3170</span>

								<br /><br />

							</div>

							<div class="url">

								<div>Shareholder website:</div>

								<a href="http://www.computershare.com/investor">www.computershare.com/investor</a>

								<br /><br />

							</div>

							<div class="url">

								<div>Shareholder online inquiries:</div>

								<a href="https://www-us.computershare.com/investor/contact">https://www-us.computershare.com/investor/contact</a>

							</div>

						</div>

						<h3>Independent Registered Public<br />Accounting Firm</h3>

						<p>Ernst &amp; Young LLP<br />Boston, Massachusetts</p>

						<h3>Annual Meeting</h3>

						<p>The 2014 annual meeting of stockholders will take place on Tuesday, May 6, 2014, beginning at 11:00 a.m. Eastern Time at Boston Scientific's Corporate Headquarters located at One Boston Scientiﬁc Place, Natick, MA 01760.</p>

						<h3>Other Information</h3>

						<p>Copies of the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports are available free of charge on our website at www.bostonscientific.com. Our Corporate Governance Guidelines and our Code of Conduct — which applies to all our directors, officers and employees, including our Chief Executive Officer and Chief Financial Officer — are also available on our website.</p>

						<p>Certifications of the Chief Executive Officer and Chief Financial Officer certifying the accuracy of the Company’s public disclosures have been filed with the Securities and Exchange Commission as exhibits to the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.</p>

						<p>Copies of these reports are also available by directing requests to:</p>

						<div class="vcard">

							<div class="fn n org">

								<div>Investor Relations</div>

								<div>Boston Scientific Corporation</div>

							</div>

							<div class="adr">

								<div class="street-address">One Boston Scientific Place</div>

								<span class="locality">Natick</span>,

								<span class="region">MA</span>,

								<span class="postal-code">01760-1537</span>

							</div>

							<div class="tel">508-650-8555</div>

							<div class="tel">508-647-2200 (Facsimile)</div>

							<div class="email">

								<a href="mailto:Investor_Relations@bsci.com">Investor_Relations@bsci.com</a>

							</div>

						</div>

						<h3>Safe Harbor for Forward-<br />Looking Statements</h3>

						<p>This Annual Report contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may be identified by words like &ldquo;anticipate,&rdquo; &ldquo;expect,&rdquo; &ldquo;project,&rdquo; &ldquo;believe,&rdquo; &ldquo;plan,&rdquo; &ldquo;may,&rdquo; &ldquo;estimate,&rdquo; &ldquo;intend&rdquo; and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. Forward-looking statements include, among other things, statements regarding our expected sales and adjusted earnings and cash flows; our financial performance; our business plans; our positioning for growth; our cost savings strategies and growth initiatives, including our emerging markets strategy and investments, and their impact on our businesses; future and completed acquisitions, investments, divestitures, alliances and collaborations and their impact on our businesses; our market estimates and changes in the market and our market share for our businesses; clinical trials, including timing and results; the strength of and expectations for our current and future product portfolio, including the impact our products will have on our businesses and financial results, markets, patients and the healthcare system generally; product development and iterations; research and development efforts and investments; the strength of our technologies and pipeline; regulatory approvals; our sales and marketing strategy; and our sustainability initiatives. Factors that may cause actual results to differ materially from those contemplated by the statements in this Annual Report can be found in our Annual Report on Form 10-K for the year ended December 31, 2013, under the headings &ldquo;Risk Factors&rdquo; and &ldquo;Safe Harbor for Forward-Looking Statements.&rdquo; Accordingly, you are cautioned not to place undue reliance on any of our forward-looking statements. We disclaim any intention or obligation to publicly update or revise any forward-looking statements. This cautionary statement is applicable to all forward-looking statements contained in this document.</p>

						<h3>Investor Information Requests</h3>

						<p>Investors, stockholders and security analysts seeking information about Boston Scientific should refer to our website at <a href="http://www.bostonscientific.com">www.bostonscientific.com</a> or contact Investor Relations at 508-650-8555, or by email at <a href="mailto:Investor_Relations@bsci.com">Investor_Relations@bsci.com</a>.</p>

						<h3>Corporate Headquarters</h3>

						<div class="vcard">

							<div class="fn n org">

								<div>Boston Scientific Corporation</div>

							</div>

							<div class="adr">

								<div class="street-address">One Boston Scientific Place</div>

								<span class="locality">Natick</span>,

								<span class="region">MA</span>,

								<span class="postal-code">01760-1537</span>

							</div>

							<div class="tel">508-650-8000</div>

							<br />

							<div class="tel">

								<div>Investor Relations Facsimile</div>

								508-647-2200

							</div>

							<div class="url">

								<a href="http://www.bostonscientific.com">www.bostonscientific.com</a>

							</div>

						</div>

						<p>Information on or connected to our website (or the website of any third party) referenced in this Annual Report is in addition to and not a part of or incorporated by reference into this Annual Report. Such additional information speaks as of the date thereof and is not intended to be confirmed or updated by reference to it herein. Boston Scientific disclaims any liability or responsibility for or endorsement of the information on or connected to the website of a third party.</p>

					</div>

				</section>

				<p>&nbsp;</p>

				<section class="non-gaap-reconciliations">

					<header>

						<h2 class="title">Non-GAAP Reconciliations</h2>

					</header>

					<img class="charts" src="a/img/chart-1.png" alt="Chart">

					<div class="chart-1">

						<div class="chart-l">

							<strong>Earnings Per Diluted Share</strong><br />

						</div>

						<div class="chart-r">

							<strong>2013</strong>

						</div>

						<div class="chart-clear"></div>

						<div class="container-1">

							<div class="chart-l">

									<strong>GAAP net (loss) income per share</strong><br />
									<strong>Non-GAAP adjustments:</strong>

										<ul>

											<li>Goodwill and other intangible asset impairment charges</li>
											<li>Acquisition- and divestiture-related net charges</li>
											<li>Restructuring-related charges</li>
											<li>Litigation-related charges</li>
											<li>Debt extinguishment charges</li>
											<li>Discrete tax items</li>
											<li>Amortization expense</li>

										</ul>

							</div>

							<div class="chart-r">

								<strong>$(0.09)</strong><br />
								<strong>&nbsp;</strong>

								<ul>
									<li>0.35 *</li>
									<li>- *</li>
									<li>0.07 *</li>
									<li>0.11 *</li>
									<li>0.03 *</li>
									<li>(0.01) *</li>
									<li>0.27 *</li>
								</ul>

							</div>

							<div class="chart-clear"></div>

						</div>

						<div class="container-2">

							<div class="chart-l">

								<strong>Adjusted net income per share</strong>

							</div>

							<div class="chart-r">

								<strong>$0.73</strong>

							</div>

							<div class="chart-clear"></div>

						</div>

						<p>*Assumes dilution of 19.5 million shares for the year ended December 31, 2013 for all or a portion of these non-GAAP adjustments.</p>

					</div> 

					<p>&nbsp;</p>

					<img class="charts" src="a/img/chart-2.png" alt="Chart">

					<div class="chart-1">

						<div class="chart-top">

							<strong>2013 vs 2012 Revenue and Relative Changes</strong>

						</div>

						<div class="chart-wrap">

							<div class="chart-name">

								&nbsp;<br />
								(Dollars in millions)

							</div>

							<div class="chart-special">

								<span class="label-border">&nbsp;&nbsp;&nbsp;&nbsp;Year Ended December 31,</span><br />2013<span class="margin">2012</span>

							</div>

							<div class="chart-info">

								As Reported<br />Currency Basis

							</div>

							<div class="chart-info">

								Less: Impact of<br />Foreign Currency
								
							</div>

							<div class="chart-info">

								Constant<br />Currency Basis
								
							</div>

							<div class="chart-clear"></div>

						</div>

						<div class="chart-wrap">

							<div class="chart-name">

								Interventional Cardiology (IC)<br />
								Peripheral Interventions

							</div>

							<div class="chart-info">

								$1,997<br />789

							</div>

							<div class="chart-info">

								$2,179<br />774

							</div>

							<div class="chart-info">

								-8%<br />2%

							</div>

							<div class="chart-info">

								-3%<br />-4%
								
							</div>

							<div class="chart-info">

								-6%<br />6%
								
							</div>

							<div class="chart-clear"></div>

						</div>

						<div class="chart-wrap">

							<div class="chart-name">

								<strong>Cardiovascular</strong><br />
								&nbsp;<br />
								Cardiac Rhythm Management<br />
								Electrophysiology

							</div>

							<div class="chart-info">

								2,786<br />&nbsp;<br />1,886<br />155

							</div>

							<div class="chart-info">

								2,953<br />&nbsp;<br />1,908<br />147

							</div>

							<div class="chart-info">

								-6%<br />&nbsp;<br />-1%<br />5%

							</div>

							<div class="chart-info">

								-3%<br />&nbsp;<br />-1%<br />-1%
								
							</div>

							<div class="chart-info">

								-3%<br />&nbsp;<br />0%<br />7%
								
							</div>

							<div class="chart-clear"></div>

						</div>

						<div class="chart-wrap">

							<div class="chart-name">

								<strong>Rhythm Management</strong><br />
								&nbsp;<br />
								Endoscopy<br />
								Urology and Women’s Health<br />
								Neuromodulation

							</div>

							<div class="chart-info">

								2,041<br />&nbsp;<br />1,300<br />505<br />453

							</div>

							<div class="chart-info">

								2,055<br />&nbsp;<br />1,252<br />500<br />367

							</div>

							<div class="chart-info">

								-1%<br />&nbsp;<br />4%<br />1%<br />23%

							</div>

							<div class="chart-info">

								-1%<br />&nbsp;<br />-3%<br />-2%<br />0%
								
							</div>

							<div class="chart-info">

								0%<br />&nbsp;<br />7%<br />3%<br />24%

							</div>

							<div class="chart-clear"></div>

						</div>

						<div class="chart-wrap">

							<div class="chart-name">

								<strong>MedSurg</strong><br />&nbsp;

							</div>

							<div class="chart-info">

								2,258<br />&nbsp;

							</div>

							<div class="chart-info">

								2,119<br />&nbsp;

							</div>

							<div class="chart-info">

								7%<br />&nbsp;

							</div>

							<div class="chart-info">

								-3%<br />&nbsp;
								
							</div>

							<div class="chart-info">

								9%<br />&nbsp;

							</div>

							<div class="chart-clear"></div>

						</div>

						<div class="chart-wrap">

							<div class="chart-name">

								<strong>Subtotal Core Businesses</strong><br />
								Divested Businesses

							</div>

							<div class="chart-info">

								<strong>7,085</strong><br />58

							</div>

							<div class="chart-info">

								<strong>7,127</strong><br />122

							</div>

							<div class="chart-info">

								-1%<br />N/A

							</div>

							<div class="chart-info">

								-2%<br />&nbsp;
								
							</div>

							<div class="chart-info">

								2%<br />N/A
								
							</div>

							<div class="chart-clear"></div>

						</div>

						<div class="chart-wrap-bold">

							<div class="chart-name">

								<strong>Worldwide Sales (GAAP)</strong>

							</div>

							<div class="chart-info">

								<strong>$7,143</strong>

							</div>

							<div class="chart-info">

								<strong>$7,249</strong>

							</div>

							<div class="chart-info">

								-1%

							</div>

							<div class="chart-info">

								-2%
								
							</div>

							<div class="chart-info">

								1%

							</div>

							<div class="chart-clear"></div>

						</div>

						<div class="chart-wrap-bold">

							<div class="chart-middle">

								&nbsp;<br />
								<strong>BRIC (year-over-year relative change)</strong><br />
								<strong>Emerging Markets (year-over-year relative change)</strong><br />
								&nbsp;<br />
								IC Sales (year-over-year relative change)<br />
								DES Sales (year-over-year relative change)<br />
								<strong>IC Sales excluding DES Sales (year-over-year relative change)</strong>

							</div>

							<div class="chart-info">

								&nbsp;<br />
								25%<br />
								17%<br />
								&nbsp;<br />
								-8%<br />
								<div class="chart-lower">
									(-13%)
								</div>
								<strong>-2%</strong>

							</div>

							<div class="chart-info">

								&nbsp;<br />
								-2%<br />
								-3%<br />
								&nbsp;<br />
								-3%<br />
								<div class="chart-lower">
									(-2%)
								</div>
								<strong>-3%</strong>
								
							</div>

							<div class="chart-info">

								&nbsp;<br />
								27%<br />
								20%<br />
								&nbsp;<br />
								-6%<br />
								<div class="chart-lower">
									(-10%)
								</div>
								<strong>1%</strong>

							</div>

							<div class="chart-clear"></div>

						</div>

					</div>

						<div class="chart-end">

							<div class="chart-name">

								Worldwide Sales (GAAP)<br />
								&nbsp;&nbsp;Divested Businesses Sales<br />
								&nbsp;&nbsp;Foreign Currency Impact

							</div>

							<div class="chart-info">

								$7,143<br />-58<br />156

							</div>

							<div class="chart-info">

								$7,249<br />-122<br />&mdash;

							</div>

							<div class="chart-clear"></div>

							<div class="chart-border"></div>

						</div>

						<div class="chart-end">

							<div class="chart-name">

								<strong>Operational Sales</strong>

							</div>

							<div class="chart-info">

								<strong>$7,241</strong>

							</div>

							<div class="chart-info">

								<strong>$7,127</strong>

							</div>

							<div class="chart-clear"></div>

							<div class="chart-border-bold"></div>

						</div>



				</section>

			</div>

		</div>

	</div>

	<footer id="footer" role="contentinfo">

		<div class="wrap">

			<div class="social">

			</div>

			<nav id="secondary-nav" role="">
				<ul>
					<li><a target="_blank" href="http://phx.corporate-ir.net/phoenix.zhtml?c=62272&p=irol-irhome">Investors&nbsp;</a></li>
					<li><a target="_blank" href="http://news.bostonscientific.com/">News&nbsp;</a></li>
					<li><a target="_blank" href="http://www.bostonscientific.com/en-US/about-us.html">About Us&nbsp;</a></li>
					<li><a target="_blank" href="http://www.bostonscientific.com/en-US/privacy-policy.html">Website Privacy Policy&nbsp;</a></li>
					<li><a target="_blank" href="http://www.bostonscientific.com/en-US/terms-of-use.html">Terms of Use&nbsp;</a></li>
					<li><a target="_blank" href="http://www.bostonscientific.com/en-US/copyright-notice.html">Copyright Notice&nbsp;</a></li>
				</ul>
			    <br>
			</nav>

			<p id="copyright">

				<small>&copy; 2014 Boston Scientific or its affiliates. All rights reserved.</small>

			</p>

		</div>

	</footer>

	<script src="http://ajax.googleapis.com/ajax/libs/jquery/1.11.0/jquery.min.js"></script>

	<script>

		window.jQuery || document.write("<script src='/a/js/jquery.js'>\x3C/script>")

	</script>

	<!--[if lt IE 9]>

		<script src="a/js/selectivizr.js"></script>

	<![endif]-->

	<script src="a/js/matchmedia.js"></script>

	<script src="a/js/picturefill.js"></script>

	<!-- Functions -->

	<script src="a/js/functions.js"></script>

	<!-- Sharing -->

	<script type="text/javascript">

		var switchTo5x=true;

	</script>

	<script type="text/javascript" src="http://w.sharethis.com/button/buttons.js"></script>

	<script type="text/javascript">

		stLight.options({

			publisher: "ur-5ce9548-708f-ba67-732d-51a5e8cd8256",
			doNotHash: true,
			doNotCopy: true,
			hashAddressBar: false

		});

	</script>

	<!-- SiteCatalyst code version: H.9. -->
	<script src="http://www.bostonscientific.com/js/s_code.js" language="JavaScript"></script>
	<script language="JavaScript">
	<!--
	s.pageName="2013AnnualReport:corporate-information"
	s.server=""
	s.channel=""
	s.pageType=""
	s.prop3="bostonscientific.com"
	s.prop4=""
	s.prop5=""
	s.prop6=""
	s.prop7=""
	s.prop8=""
	s.prop9=""
	s.prop10=""
	/* E-commerce Variables */
	s.campaign=""
	s.state=""
	s.zip=""
	s.events=""
	s.products=""
	s.purchaseID=""
	s.eVar1=""
	s.eVar3=""
	s.eVar4=""
	s.eVar5=""
	s.eVar6=""
	s.eVar7=""
	s.eVar8=""
	s.eVar9=""
	s.eVar10=""
	s.eVar11=""
	s.eVar12=""
	s.eVar13=""
	s.eVar14=""
	s.eVar15=""
	/************* DO NOT ALTER ANYTHING BELOW THIS LINE ! **************/
	var s_code=s.t();if(s_code)document.write(s_code)//-->
	</script>
	<!--/DO NOT REMOVE/-->
	<!-- End SiteCatalyst code version: H.9. -->

</body>

</html>
